| ABR-OPA1-03178-R100 | PAb to CD29 [beta1 Integrin] (human) (phosphorylated) (pThr788/pThr789) | 100 µl |
| ABR-OPA1-03179-R100 | PAb to CD61 [beta3 Integrin] (human) (phosphorylated) (pTyr773) | 100 µl |
| ABR-OPA1-03180-R100 | PAb to CD61 [beta3 Integrin] (human) (phosphorylated) (pTyr785) | 100 µl |
| ABR-OPA1-03181-R100 | PAb to Insulin Receptor Substrate-1 [IRS-1] (human) (phosphorylated) (pTyr1179) | 100 µl |
| ABR-OPA1-03182-R100 | PAb to Insulin Receptor Substrate-1 [IRS-1] (human) (phosphorylated) (pTyr1225) | 100 µl |
| ABR-OPA1-03183-R100 | PAb to Insulin Receptor Substrate-1 [IRS-1] (human) (phosphorylated) (pTyr612) | 100 µl |
| ABR-OPA1-03184-R100 | PAb to Insulin Receptor Substrate-1 [IRS-1] (human) (phosphorylated) (pTyr896) | 100 µl |
| ABR-OPA1-03185-R100 | PAb to Insulin Receptor Substrate-1 [IRS-1] (human) (phosphorylated) (pTyr941) | 100 µl |
| ABR-OPA1-03186-R100 | PAb to Insulin Receptor Substrate-1 [IRS-1] (human) (phosphorylated) (pSer312) | 100 µl |
| ABR-OPA1-03187-R100 | PAb to Insulin Receptor Substrate-1 [IRS-1] (human) (phosphorylated) (pSer616) | 100 µl |
| ABR-OPA1-03188-R200 | PAb to Insulin Receptor Substrate-2 [IRS-2] (phosphorylated) (pSer731) | 200 µl |
| ABR-OPA1-03189-R100 | PAb to Vascular Endothelial Growth Factor Receptor 2 [VEGFR2] (mouse) (phosphorylated) (pTyr1054) | 100 µl |
| ABR-OPA1-03190-R100 | PAb to Vascular Endothelial Growth Factor Receptor 2 [VEGFR2] (phosphorylated) (pTyr1214) | 100 µl |
| ABR-OPA1-03191-R100 | PAb to Vascular Endothelial Growth Factor Receptor 2 [VEGFR2] (phosphorylated) (pTyr951) | 100 µl |
| ABR-OPA1-03192-R100 | PAb to Vascular Endothelial Growth Factor Receptor 2 [VEGFR2] (mouse) (phosphorylated) (pTyr1054/pTyr1059) | 100 µl |
| ABR-OPA1-03200-C050 | PAb to Retinoblastoma Protein [Rb] (human) (phosphorylated) (pThr356) | 50 µg |
| ABR-OPA1-03201-R100 | PAb to Retinoblastoma Protein [Rb] (phosphorylated) (pSer807/811) | 100 µl |
| ABR-OPA1-03202-C050 | PAb to Retinoblastoma Protein [Rb] (human) (phosphorylated) (pThr826) | 50 µg |
| ABR-OPA1-03354-C100 | PAb to Interleukin-13 [IL-13] (human) (Biotin) | 100 µg |
| ABR-OPA1-03357-C500 | PAb to Interleukin-15 [IL-15] (human) | 500 µg |
| ABR-OPA1-03358-C100 | PAb to Interleukin-15 [IL-15] (human) (Biotin) | 100 µg |
| ABR-OPA1-03359-C500 | PAb to Interleukin-15 [IL-15] (human) | 500 µg |
| ABR-OPA1-03361-C050 | PAb to Interleukin-16 [IL-16] (human) | 50 µg |
| ABR-OPA1-03885-R100 | PAb to Focal Adhesion Kinase [FAK] (mouse) (phosphorylated) (pSer732) | 100 µl |
| ABR-OPA1-03886-R100 | PAb to Focal Adhesion Kinase [FAK] (mouse) (phosphorylated) (pSer843) | 100 µl |
| ABR-OPA1-03887-R100 | PAb to Focal Adhesion Kinase [FAK] (phosphorylated) (pTyr407) | 100 µl |
| ABR-OPA1-03888-R100 | PAb to Focal Adhesion Kinase [FAK] (phosphorylated) (pTyr576) | 100 µl |
| ABR-OPA1-03889-R100 | PAb to Focal Adhesion Kinase [FAK] (phosphorylated) (pTyr577) | 100 µl |
| ABR-OPA1-03891-R100 | PAb to Retinoblastoma Protein [Rb] (human) (phosphorylated) (pSer612) | 100 µl |
| ABR-OPA1-03892-R100 | PAb to Retinoblastoma Protein [Rb] (human) (phosphorylated) (pSer780) | 100 µl |
| ABR-OPA1-03893-R100 | PAb to Retinoblastoma Protein [Rb] (human) (phosphorylated) (pSer807) | 100 µl |
| ABR-OPA1-03894-R100 | PAb to Retinoblastoma Protein [Rb] (human) (phosphorylated) (pSer811) | 100 µl |
| ABR-OPA1-03896-R100 | PAb to Retinoblastoma Protein [Rb] (phosphorylated) (pSer249/pThr252) | 100 µl |
| ABR-OPA1-03898-R100 | PAb to Retinoblastoma Protein [Rb] (phosphorylated) (pThr821) | 100 µl |
| ABR-OPA1-04001-C010 | PAb to Synapsin I | 10 µg |
| ABR-OPA1-04011-C025 | PAb to NMDA Receptor Type 1 (N1 Variant) (rat) | 25 µg |
| ABR-OPA1-04012-C025 | PAb to NMDA Receptor Type 1 (C1 Variant) (rat) | 25 µg |
| ABR-OPA1-04013-C025 | PAb to NMDA Receptor Type 1 (C2 Variant) (rat) | 25 µg |
| ABR-OPA1-04014-C025 | PAb to NMDA Receptor Type 1 (C2' Variant) (rat) | 25 µg |
| ABR-OPA1-04020-C010 | PAb to NMDA Receptor Type 2 | 10 µg |
| ABR-OPA1-04021-C010 | PAb to NMDA Receptor Type 2A | 10 µg |
| ABR-OPA1-04022-C010 | PAb to NMDA Receptor Type 2B | 10 µg |
| ABR-OPA1-04050-R100 | PAb to Tyrosine Hydroxylase [TH] | 100 µl |
| ABR-OPA1-04060-R100 | PAb to Metabotropic Glutamate Receptor 1alpha [mGIuR1alpha] | 100 µl |
| ABR-OPA1-04061-R100 | PAb to Metabotropic Glutamate Receptor 2/3 [mGluR2/3] | 100 µl |
| ABR-OPA1-04063-R100 | PAb to Metabotropic Glutamate Receptor 5/1 [mGluR5/1] | 100 µl |
| ABR-OPA1-04100-R100 | PAb to GABA-A Receptor alpha1 | 100 µl |
| ABR-OPA1-04102-R100 | PAb to GABA-A Receptor alpha4 | 100 µl |
| ABR-OPA1-04103-R100 | PAb to GABA-A Receptor alpha4 | 100 µl |
| ABR-OPA1-04104-R100 | PAb to GABA-A Receptor alpha5 | 100 µl |
| ABR-OPA1-04105-R100 | PAb to GABA-A Receptor alpha6 | 100 µl |
| ABR-OPA1-04106-R100 | PAb to GABA-A Receptor beta1 | 100 µl |
| ABR-OPA1-04107-R100 | PAb to GABA-A Receptor beta2 | 100 µl |
| ABR-OPA1-04108-R100 | PAb to GABA-A Receptor beta3 | 100 µl |
| ABR-OPA1-04110-R100 | PAb to GABA-A Receptor gamma2 | 100 µl |
| ABR-OPA1-04111-R050 | PAb to GABA-A Receptor gamma2 | 50 µl |
| ABR-OPA1-04112-R050 | PAb to GABA-A Receptor alpha2 | 50 µl |
| ABR-OPA1-04114-R050 | PAb to GABA-A Receptor alpha6 | 50 µl |
| ABR-OPA1-04115-R050 | PAb to GABA-A Receptor alpha1 | 50 µl |
| ABR-OPA1-04116-R100 | PAb to NMDA Receptor Type 2B (phosphorylated) (pTyr1472) | 100 µl |
| ABR-OPA1-04117-R150 | PAb to GluR1 (phosphorylated) (pSer831) | 150 µl |
| ABR-OPA1-04118-R150 | PAb to GluR1 (phosphorylated) (pSer845) | 150 µl |
| ABR-OPA1-04119-R100 | PAb to GABA-B Receptor (rat) (phosphorylated) (pSer892) | 100 µl |
| ABR-OPA1-06100-C050 | PAb to Glial Fibrillary Acid Protein [GFAP] | 50 µg |
| ABR-OPA1-07001-R200 | PAb to NEDD8 | 200 µl |
| ABR-OPA1-07200-R200 | PAb to SUMO-1 | 200 µl |
| ABR-OPA1-08010-C100 | PAb to MMP-1, Hemopexin Domain (human) | 100 µg |
| ABR-OPA1-08011-C100 | PAb to MMP-1, Hinge Region (human) | 100 µg |
| ABR-OPA1-08012-C100 | PAb to MMP-1 (CT) (human) | 100 µg |
| ABR-OPA1-08013-C100 | PAb to MMP-1 (NT) (human) | 100 µg |
| ABR-OPA1-08014-C100 | PAb to MMP-1, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08020-C100 | PAb to MMP-2, Hemopexin Domain (human) | 100 µg |
| ABR-OPA1-08021-C100 | PAb to MMP-2 (NT) (human) | 100 µg |
| ABR-OPA1-08022-C100 | PAb to MMP-2, Hinge Region (human) | 100 µg |
| ABR-OPA1-08023-C100 | PAb to MMP-2 (CT) (human) | 100 µg |
| ABR-OPA1-08024-C100 | PAb to MMP-2, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08030-C100 | PAb to MMP-3, Hinge Region (human) | 100 µg |
| ABR-OPA1-08031-C100 | PAb to MMP-3 (CT) (human) | 100 µg |
| ABR-OPA1-08032-C100 | PAb to MMP-3 (CT) (human) | 100 µg |
| ABR-OPA1-08033-C100 | PAb to MMP-3, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08070-C100 | PAb to MMP-7 (NT) (human) | 100 µg |
| ABR-OPA1-08071-C100 | PAb to MMP-7, Zinc Site (human) | 100 µg |
| ABR-OPA1-08072-C100 | PAb to MMP-7 (human) | 100 µg |
| ABR-OPA1-08073-C100 | PAb to MMP-7, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08080-C100 | PAb to MMP-8, Hinge Region (human) | 100 µg |
| ABR-OPA1-08081-C100 | PAb to MMP-8 (NT) (human) | 100 µg |
| ABR-OPA1-08082-C100 | PAb to MMP-8 (CT) (human) | 100 µg |
| ABR-OPA1-08083-C100 | PAb to MMP-8, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08090-C100 | PAb to MMP-9 (CT) (human) | 100 µg |
| ABR-OPA1-08091-C100 | PAb to MMP-9 (NT) (human) | 100 µg |
| ABR-OPA1-08092-C100 | PAb to MMP-9, Hinge Region (human) | 100 µg |
| ABR-OPA1-08093-C100 | PAb to MMP-9, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08094-C100 | PAb to MMP-9 (human) | 100 µg |
| ABR-OPA1-08110-C100 | PAb to MMP-11 (NT) (human) | 100 µg |
| ABR-OPA1-08111-C100 | PAb to MMP-11, Hinge Region (human) | 100 µg |
| ABR-OPA1-08112-C100 | PAb to MMP-11 (CT) (human) | 100 µg |
| ABR-OPA1-08113-C100 | PAb to MMP-11, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08120-C100 | PAb to MMP-12, Hinge Region (human) | 100 µg |
| ABR-OPA1-08121-C100 | PAb to MMP-12 (NT) (human) | 100 µg |
| ABR-OPA1-08122-C100 | PAb to MMP-12 (CT) (human) | 100 µg |
| ABR-OPA1-08123-C100 | PAb to MMP-12, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08130-C100 | PAb to MMP-13, Hinge Region (human) | 100 µg |
| ABR-OPA1-08131-C100 | PAb to MMP-13 (NT) (human) | 100 µg |
| ABR-OPA1-08132-C100 | PAb to MMP-13 (CT) (human) | 100 µg |
| ABR-OPA1-08133-C100 | PAb to MMP-13, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08140-C100 | PAb to MMP-14, Hinge Region (human) | 100 µg |
| ABR-OPA1-08141-C100 | PAb to MMP-14 (NT) (human) | 100 µg |
| ABR-OPA1-08142-C100 | PAb to MMP-14, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08160-C100 | PAb to MMP-16, Hinge Region (human) | 100 µg |
| ABR-OPA1-08180-C100 | PAb to MMP-18 (NT) (human) | 100 µg |
